This generally well-conducted review compared the morbidity and mortality associated with off-pump coronary artery bypass surgery (OPCAB) with that of conventional bypass surgery. Randomised controlled trials showed no difference in morbidity or mortality, apart from the incidence of atrial fibrillation. Observational studies showed OPCAB to be more favourable. The authors' conclusions are likely to be reliable, but the generalisability of the results is less certain.
Data extraction
Two reviewers extracted the data and any disagreements were resolved by consensus. The analysis was conducted on an intention-to-treat basis. The number and proportion of participants experiencing each outcome were extracted.
Methods of synthesis
How were the studies combined? The results from RCTs were pooled separately to those from observational studies. A fixed-effect model was used to pool the data where there was no significant heterogeneity, otherwise a random-effects model was used. ORs with 95% CIs were presented for dichotomous outcomes, while continuous outcomes were expressed as weighted mean differences with 95% CIs.
How were differences between studies investigated?
The studies were grouped according to their design and study details, and the results of the quality assessment were tabulated. Heterogeneity was assessed using the Q statistic. A post hoc analysis was undertaken to investigate any heterogeneity. Sensitivity analyses were conducted to assess the effects of study quality.
Results of the review
Thirty-seven RCTs (3,449 participants) and 19 observational studies (293,617 participants) were included.
Short-term outcomes.
Ten RCTs showed no difference in 30-day mortality between OPCAB and CCAB (OR 0.91, 95% CI: 0.45, 1.83). Fourteen observational studies showed a decrease in mortality associated with OPCAB (OR 0.72, 95% CI: 0.66, 0.78, P<0.00001).
Twelve RCTs showed no statistically significant reduction in stroke with OPCAB (OR 0.51, 95% CI: 0.25, 1.05, P=0.07). Fifteen observational studies showed a reduction in stroke associated with OPCAB (OR 0.62, 95% CI: 0.55, 0.69, P<0.00001).
Nineteen RCTs showed no statistically significant reduction in MI with OPCAB (OR 0.79, 95% CI: 0.50, 1.25). Six observational studies showed a reduction in MI associated with OPCAB (OR 0.66, 95% CI: 0.50, 0.88, P=0.004).
Eighteen RCTs showed a reduction in atrial fibrillation with OPCAB (OR 0.59, 95% CI: 0.46, 0.77, P<0.00001), although there was significant heterogeneity (P=0.09). Stratified analyses showed that the levels of atrial fibrillation in the control groups and baseline atrial fibrillation levels explained this heterogeneity. Four observational studies showed a reduction in atrial fibrillation associated with OPCAB (OR 0.78, 95% CI: 0.74, 0.82, P<0.0001).
Five RCTs showed no difference in acute renal failure between OPCAB and CCAB (OR 0.61, 95% CI: 0.25, 1.47) . Eight observational studies showed a reduction in acute renal failure with OPCAB (OR 0.54, 95% CI: 0.39, 0.77, P=0.0006).
The results for other outcomes were also reported.
Long-term outcomes.
Five RCTs showed no differences in 1-to 2-year mortality (OR 0.82, 95% CI: 0.40, 1.68), MI (OR 0.61, 95% CI: 0.32, 1.18) or revascularisation (OR 1.72, 95% CI: 0.78, 3.94) between OPCAB and CCAB.
Two observational studies showed no differences in 1-to 2-year mortality (OR 1.01, 95% CI: 0.74, 1.40), MI (OR 0.91, 95% CI: 0.55, 1.49) or revascularisation (OR 1.35, 95% CI: 0.76, 2.39) between OPCAB and CCAB.
In the RCTs, the mean number of bypass grafts was lower in the OPCAB group than in the CCAB group (difference -0.19, 95% CI: -0.25, -0.13, P<0.0001).
